封面
市場調查報告書
商品編碼
921961

全球電刺激設備市場:成長,趨勢,及預測

Electrical Stimulation Devices Market - Growth, Trends, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供全球電刺激設備市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,設備類型·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 慢性疾病,神經病變,脊髓損傷的發生率的增加
    • 久坐不動的生活方式導致慢性健康問題
  • 市場阻礙因素
    • 設備核準的嚴格法規
    • 提供多種電刺激系統
  • 波特的五力分析

第5章 市場區隔

  • 不同設備類型
    • 腦深部刺激設備
    • 脊髓刺激設備
    • 薦椎神經刺激設備
    • 迷走神經刺激設備
    • 神經肌肉電刺激設備
    • 其他
  • 各用途
    • 肌肉骨骼障礙的管理
    • 疼痛的管理
    • 代謝與GIT管理
    • 神經病變及異動症的管理
    • 失禁管理
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • DJO Global, Inc.
    • BTL Corporate
    • Nevro Corp.
    • NeuroMetrix, Inc.
    • Zynex Medical
    • Cogentix Medical
    • BioMedical Life Systems

第7章 市場機會及今後趨勢

簡介目錄
Product Code: 67514

The Electrical Stimulation Devices market studied is anticipated to grow with a CAGR of 9.5%, during the forecast period. The major factors attributing to the growth of the electrical stimulation devices market are the growing incidence of spinal injury triggered by accidents, violence, or falling anticipated to boost the demand for spinal surgery, which is assessed to upsurge the market growth for electrical stimulation devices.

As per the NINDS 2019 Factsheet, there are around 12,000 estimated spinal cord injuries in the United States each year. Falls are the world's second primary cause of unintentional or accidental fatalities from injuries. According to the WHO 2018 data every year there are 37.3 million cases that are serious enough to require medical care and around 646,000 people die globally each year from falls which are expected to further boost the demand for electrical stimulation devices for treatment.

Key Market Trends

Pain Management is Expected to Hold the Largest Market Share in the Electrical Stimulation Devices Market

The dominant share is retained by the pain management segment owing to the attributes such as the strong prevalence of chronic pain ailments and increased use of products to manage pain owing to their high therapeutic benefits.

Chronic pain is among the world's leading causes of suffering and injury, and a prominent indication of both AIDS/HIV and cancer. As per the statistics from the American Academy of Pain Medicine 2018, around 126 million individuals experience pain in the US. It is known that chronic pain affects more than 1.5 billion people worldwide. Therefore the increasing chronic pain among the individuals is found increasing the overall market share.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall electrical stimulation devices market, throughout the forecast period. This is owing to factors such as the rising prevalence of chronic disorders. An estimated 45 percent or about 33 million Americans were diagnosed with at least one chronic disease, according to the National Center for Biotechnology Information (NCBI), March 2018. Therefore the increase in chronic pain is further expected to upsurge the demand of stimulator devices in the coming years.

Additionally, the presence of key players that manufacture electrical muscle stimulation devices in the region will continue to drive the market's growth in the United States throughout the projected period.

Competitive Landscape

The electrical stimulation devices market is moderately competitive and consists of a few major players. In terms of market share, the market is currently dominated by a few of the major players. Some leading players are making intensive investments and launching new products with the other organizations to expand their global market positions. Some of the companies which are currently dominating the market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, BTL Corporate, and DJO Global, Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Incidence of Chronic Diseases, Neurological Disorders and Spinal Injuries
    • 4.2.2 Deskbound Ways of life that lead to Chronic Health Issues
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulation for Device Approval
    • 4.3.2 Availability of Wide Range of Alternatives for Electrical Stimulation Systems
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Deep Brain Stimulation Devices
    • 5.1.2 Spinal Cord Stimulation Devices
    • 5.1.3 Sacral Nerve Stimulation Devices
    • 5.1.4 Vagus Nerve Stimulation Devices
    • 5.1.5 Neuromuscular Electrical Stimulation Devices
    • 5.1.6 Other Electrical Stimulation Devices
  • 5.2 By Application
    • 5.2.1 Musculoskeletal Disorder Management
    • 5.2.2 Pain Management
    • 5.2.3 Metabolism & GIT Management
    • 5.2.4 Neurological and Movement Disorder Management
    • 5.2.5 Incontinence Management
    • 5.2.6 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic plc
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Abbott Laboratories
    • 6.1.4 DJO Global, Inc.
    • 6.1.5 BTL Corporate
    • 6.1.6 Nevro Corp.
    • 6.1.7 NeuroMetrix, Inc.
    • 6.1.8 Zynex Medical
    • 6.1.9 Cogentix Medical
    • 6.1.10 BioMedical Life Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS